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Background: Antifibrinolytic drugs such as epsilon aminocaproic acid 
(EACA) have been used in previous studies of retired racing 
greyhounds to prevent the occurrence of delayed post-operative 
bleeding (DPOB). The objective of this study was to build on previous 
research and minimize the number of dosages of EACA needed. 
Hypothesis: Using an abbreviated form of EACA on RRG after surgery 
can reduce the days of dosages from five to three. Animals: Four dogs 
were used in this study: two females and two males. Methods: Each 
dog underwent a gonadectomy and directly after surgery was given 
his/her first dose of EACA orally. They then received eight more doses 
orally every eight hours. Results: Using a reconstituted bottle of EACA, 
the female from the first round did not show any complications after 
surgery while the male experienced DPOB. A new bottle of EACA was 
used for the second round of dogs and neither dogs showed signs of 
DPOB. Conclusions: The abbreviated form of EACA may be effective at 
reducing delayed post-operative bleeding in retired racing greyhounds; 
however, this is impossible to conclude definitively since there is no 
way of determining prior to surgery which dogs may have been prone 
to bleeding. 
Previous Studies 
Epsilon aminocaproic acid has been used in several previous studies 
for a variety of uses. The most common test subjects for this drug 
are humans, horses, and dogs. Below are descriptions of previous 
experiments using EACA in these three sample groups. 
Humans 
• EACA was used in an experiment with 78 random 
cardiopulmonary bypass patients to evaluate whether its use 
had an effect on the number of patients that required reopening 
after surgery due to bleeding. There appeared to be no 
correlation. 
• An experiment using EACA was performed using 44 patients to 
evaluate its use for the prevention of bleeding in 
thrombocytopenic patients with hematological malignancies. 
Those receiving EACA had low risk of major bleeding. 
Horses 
• An experiment was performed to compare and predict the 
therapeutic concentrations of EACA needed in horses and 
humans after using thromboelastography and hyperfibrinolysis. 
The hypothesis that the concentration would be much lower in 
horses was supported. 
• EACA was administered intravenously to 20 clinically healthy 
horses and ponies to determine its affect on hemostasis and 
fibrinolysis. The results indicated a significant decrease in 
fibrinogen concentrations after EACA administration. 
Dogs 
• A study was performed using 46 retired racing greyhounds 
(RRGs) that required limb amputations from appendicular bone 
tumors to evaluate if EACA had an effect on the prevention of 
post operative bleeding. The study suggested that preemptive 
administration deceased the frequency of bleeding in RRGs. 
• A study was performed to compare 28 Greyhounds to 15 non-
Greyhounds using thromboelastography (TEG). Results indicated 
that clotting kinetics and clot strength were weaker in 
Greyhounds. 
*An understanding of how epsilon aminocaproic acid has been used 
in previous studies was imperative to this research so that we could 
build off of previous experiments and compare our results. 
Methods 
After undergoing a gonadectomy, each dog was given their first dose 
of EACA orally. They were then given 8 more doses orally every 8 
hours and were observed for any delayed bleeding or excessive 
bruising. 
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Results 
Martin and CoCo were the first set of Greyhounds that underwent gonadectomy which took place 
on August 25, 2015. They were both given a reconstituted form of aminocaproic acid. CoCo did not 
show signs of delayed post operative bleeding while Martin had a particularly difficult time. He 
bled and bruised excessively and required a second surgery after tearing open his stitches. Due to 
Martin's serious bleeding problem, we evaluated our methods to look for any indications as to why 
the drug may have been unsuccessful. We concluded that it could be attributed to the use of a 
reconstituted bottle of EACA rather than a new bottle. 
The second set of Greyhounds we received, Rocket and Gloria, underwent their gonadectomy on 
December 1, 2015. Both dogs were given doses of EACA out of a new bottle and neither dog 
indicated any problems with delayed post operative bleeding; yet, the results for Gloria may be 
slightly skewed considering she became sick (likely a side effect from the anesthesia) and vomited 
up her first two doses of EACA. To accommodate this, in addition to her next dose of EACA she was 
also given maropitant, an anti-nausea drug. 
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Summary and Conclusion 
Overall, due to the very small sample size it was hard to obtain any 
solid data from our research. With only 4 dogs (and two of the dogs 
possibly having inconsistent results due to the use of a 
reconstituted drug) there was simply not enough information to 
determine if the use of the EACA had any effect on delayed post 
operative bleeding. Also, going off of previous studies, there is still 
no known way to determine which dogs may or may not be prone 
to bleeding. In general, the CBCs of Greyhounds are significantly 
different in various aspects from other breeds which one would 
think would attribute to their tendency to bleed. However, although 
Greyhounds differ from other breeds, there is no data that indicates 
any differences between individual Greyhounds that might point to 
a reason why one suffers from delayed post operative bleeding and 
another does not. It is because of this that discrepancies in the 
CBCs of Greyhounds in comparison to other breeds is often 
attributed to their athletic body type. 
Nevertheless, based off of previous studies the use of epsilon 
aminocaproic acid has proven to be effective in humans, horses, 
and greyhounds. The only downfall is the time commitment 
required to administer the drug. With humans, this is not a serious 
problem considering most patients in need of this drug are 
generally hospitalized and undergoing surgery, thus, they are 
administered the drug directly from their physician. However, with 
animals, they are generally only kept one night after surgery before 
being sent home with their owner who is then required to 
administer the majority of doses by his/herself. This can be difficult 
for some owners and often results in the medicine not being given 
efficiently, leading to the delayed bleeding and possibly a second 
surgery. 
Therefore, for future research it could be very helpful to attempt to 
reduce the number of doses of EACA needed after surgery. In 
addition to this, if the causative agent for a Greyhound prone to 
bleeding could be identified, the use of EACA could be used in 
correlation with this to prevent the bleeding before it occurs. 
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